Phoenix Biotech Acquisition (Phoenix Biotech Acquisition) FCF Yield % : -4.69 (As of May. 30, 2024)

Phoenix Biotech Acquisition FCF Yield % Chart

Phoenix Biotech Acquisition Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
FCF Yield %	Get a 7-Day Free Trial					-0.30	-2.15	-1.10	-4.79	-1.51

Competitive Comparison of Phoenix Biotech Acquisition's FCF Yield %

For the Shell Companies subindustry, Phoenix Biotech Acquisition's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Phoenix Biotech Acquisition's FCF Yield % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Phoenix Biotech Acquisition's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Phoenix Biotech Acquisition's FCF Yield % falls into.

Phoenix Biotech Acquisition FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Phoenix Biotech Acquisition's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

Phoenix Biotech Acquisition's annualized FCF Yield % for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phoenix Biotech Acquisition FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Phoenix Biotech Acquisition FCF Yield % Related Terms

Thank you for viewing the detailed overview of Phoenix Biotech Acquisition's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Phoenix Biotech Acquisition (Phoenix Biotech Acquisition) Business Description